Quest Diagnostics Incorporated , the nation's leading provider of diagnostic testing, information and services, announced that Kenneth R. Finnegan, Vice President Business Development, is scheduled to speak at the Deutsche Bank Securities 27th Annual Health Care Conference on Wednesday, May 8, 2002, at the Baltimore Marriott Waterfront, Baltimore, Maryland. The Quest Diagnostics presentation is scheduled to begin at 2:00 p.m. Eastern Time.
The conference is being webcast live and can be accessed on the Internet at: http://www.visualwebcaster.com/event.asp?id=4874. You may also access the Quest Diagnostics website at: http://www.questdiagnostics.com/ . In addition, a replay of the webcast will be available for 90 days following the conference.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic testing, information and services, providing insights that enable physicians, hospitals, managed care organizations and other healthcare professionals to make decisions to improve health. The company offers the broadest access to diagnostic laboratory services through its national network of laboratories and patient service centers. Quest Diagnostics is the leading provider of esoteric testing, including gene-based medical testing, and empowers healthcare organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Additional company information can be found on the Internet at: http://www.questdiagnostics.com/ .
The statements in this press release which are not historical facts or information may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. Certain of these risks and uncertainties are listed in the Quest Diagnostics Incorporated 2001 Form 10-K and subsequent filings.
SOURCE: Quest Diagnostics Incorporated
Contact: Media - Gary Samuels, +1-201-393-5700, or Investors - Laure
Park, +1-201-393-5030, both of Quest Diagnostics Incorporated